Anti-BP180
Showing 26 - 50 of >10,000
Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)
Completed
- Colorectal Adenocarcinoma
- +4 more
- Bevacizumab
- +4 more
-
Scottsdale, Arizona
- +12 more
Jan 27, 2022
Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)
Active, not recruiting
- Recurrent Glioblastoma
- Bevacizumab
- +3 more
-
La Jolla, California
- +26 more
Jun 28, 2022
Falciparum Malaria Trial in Worldwide (Pyronaridine - artesunate, Mefloquine plus artesunate)
Completed
- Falciparum Malaria
- Pyronaridine - artesunate
- Mefloquine plus artesunate
-
Bobo Dioulasso, Houet Province, Burkina Faso
- +8 more
Oct 22, 2021
Coronavirus Trial (OVX033, Saline solution)
Not yet recruiting
- Coronavirus
- OVX033
- Saline solution
- (no location specified)
Nov 14, 2023
Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma Trial in United States (Best Practice, Blood
Recruiting
- Cardiovascular Disorder
- +8 more
- Best Practice
- +4 more
-
Creve Coeur, Missouri
- +24 more
Aug 10, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (BP1002; Liposomal Bcl-2 Antisense
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide
- Decitabine (in combination with BP1002)
- (no location specified)
Mar 8, 2022
Drug-Eluting Stents, Percutaneous Coronary Intervention Trial in Shanghai (3 months DAPT, 12 months DAPT)
Unknown status
- Drug-Eluting Stents
- Percutaneous Coronary Intervention
- 3 months DAPT
- 12 months DAPT
-
Shanghai, ChinaShanghai Zhongshan Hospital
Sep 8, 2020
Advanced or Metastatic NSCLC Trial (Ceralasertib, Durvalumab, Docetaxel)
Recruiting
- Advanced or Metastatic Non-Small Cell Lung Cancer
- Ceralasertib
- +2 more
-
Chandler, Arizona
- +80 more
Jan 12, 2023
NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in
Active, not recruiting
- Non-small Cell Lung Cancer
- Urothelial Cancer
- Avelumab 800 mg in combination with pemetrexed / carboplatin
- +3 more
-
Tucson, Arizona
- +45 more
Oct 13, 2022
Bullous Pemphigoid Trial in Bhubaneswar (Prednisolone, Dapsone, Methotrexate)
Not yet recruiting
- Bullous Pemphigoid
- Prednisolone
- +2 more
-
Bhubaneswar, Odisha, IndiaAIIMS Bhubaneswar
Aug 9, 2023
Bullous Pemphigoid Trial in Worldwide (biological, other, drug)
Recruiting
- Bullous Pemphigoid
- efgartigimod PH20 SC
- +2 more
-
Fountain Valley, California
- +24 more
Jul 27, 2022
Influenza, Human, Vaccination; Infection, Vaccines Trial in Saint Petersburg (Flu-M, Inactivated split influenza vaccine 0.5 mL,
Completed
- Influenza, Human
- +2 more
- Flu-M, Inactivated split influenza vaccine 0.5 mL
- +3 more
-
Saint Petersburg, Russian Federation
- +1 more
Jul 19, 2022
Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)
Recruiting
- Metastatic Colorectal Cancer
- RO7122290
- +2 more
-
Toronto, Ontario, Canada
- +15 more
Jan 13, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States
Active, not recruiting
- Brain Stem Glioma
- +4 more
- Bevacizumab
- +2 more
-
Birmingham, Alabama
- +136 more
Oct 15, 2022
Influenza, Flu, Human Trial in Russian Federation (Flu-M [inactivated split influenza vaccine] without preservative, Flu-M
Completed
- Influenza
- Flu, Human
- Flu-M [inactivated split influenza vaccine] without preservative
- Flu-M [inactivated split influenza vaccine] with preservative
-
Engels, Russian Federation
- +7 more
Mar 28, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +6 more
- Atezolizumab
- +2 more
-
Los Angeles, California
- +21 more
Apr 20, 2021
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +21 more
- Atezolizumab
- +8 more
-
Little Rock, Arkansas
- +97 more
Jan 27, 2023
Leishmaniasis, Cutaneous Trial in Medellín (Arnica Tincture)
Not yet recruiting
- Leishmaniasis, Cutaneous
- Arnica Tincture
-
Medellín, Antioquia, ColombiaProgram for Research and Control in Tropical Diseases - PECET
Jun 4, 2022
Acute Myeloid Leukemia (AML) Trial in United States (BP1001 in combination with Ventoclax plus decitabine, BP1001 plus
Recruiting
- Acute Myeloid Leukemia (AML)
- BP1001 in combination with Ventoclax plus decitabine
- BP1001 plus decitabine
-
Fairway, Kansas
- +5 more
Jan 3, 2022
Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States
Completed
- Fallopian Tube Carcinoma
- +37 more
- Bevacizumab
- +5 more
-
Birmingham, Alabama
- +22 more
Oct 19, 2021
Colorectal Cancer, Diet Habit Trial in Chicago (Med, WL)
Recruiting
- Colorectal Cancer
- Diet Habit
- Med
- WL
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jan 10, 2023
Hypertension Trial (Placebo, lorundrostat Dose 1, lorundrostat Dose 2)
Not yet recruiting
- Hypertension
- Placebo
- +2 more
- (no location specified)
Nov 22, 2023
Amyotrophic Lateral Sclerosis, Plasmapheresis Trial (Plasmapheresis)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- Plasmapheresis
- Plasmapheresis
- (no location specified)
Oct 3, 2022